Spiro substituted compounds as angiogenesis inhibitors

Details for Australian Patent Application No. 2008226666 (hide)

Owner ADVENCHEN LABORATORIES, LLC

Inventors Chen, Guoqing Paul

Agent La Fontaine Intellectual Property Serv.

Pub. Number AU-A-2008226666

PCT Pub. Number WO2008/112407

Priority 12/036,244 23.02.08 US; 60/941,698 04.06.07 US; 60/894,692 14.03.07 US

Filing date 24 February 2008

Wipo publication date 18 September 2008

International Classifications

C07D 401/02 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/47 (2006.01) - Quinolines

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

C07D 403/02 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

24 September 2009 PCT application entered the National Phase

  PCT publication WO2008/112407 Priority application(s): WO2008/112407

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008226667-Spiro substituted compounds as angiogenesis inhibitors

2008226649-Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof